Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer

Cancer Letters
Hellinida ThomadakiAndreas Scorilas

Abstract

Many members of BCL2 (Bcl-2) apoptosis-related genes were found to be differentially expressed in various malignancies and were proposed as prognostic cancer biomarkers. Recently, a new member of the BCL2 gene family, BCL2L12, was cloned and was found to be expressed in mammary gland. In the present study, 55 specimens from patients with, histologically confirmed, epithelial breast carcinoma were analyzed for BCL2 and BCL2L12 gene expression by RT-PCR. Increased expression of BCL2 gene was found in patients belonging to the age groups <45 or >55 years, as well as in estrogen receptors (ER)-positive patients and in BCL2L12-positive tumors. In addition, BCL2 or BCL2L12-positive patients were found to be almost four times less likely to relapse or die in comparison to BCL2 or BCL2L12-negative patients, respectively. Multivariate analysis revealed that BCL2 and BCL2L12 might be used as independent prognostic biomarkers in breast cancer.

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M KatsumataJ C Reed
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·Y Tsujimoto, C M Croce
May 1, 1995·British Journal of Cancer·G FontaniniG Bevilacqua
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J NixonJ R Harris
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B N AmesT M Hagen
Dec 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BinderW Hiddemann
Oct 23, 1997·Journal of the National Cancer Institute·W B Ershler, D L Longo
Mar 13, 1999·International Journal of Cancer. Journal International Du Cancer·D M ParkinJ Ferlay
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 19, 2000·Hematology/oncology Clinics of North America·R Yancik, L A Ries
Mar 25, 2000·Endocrine-related Cancer·S KrajewskiJ C Reed
Jul 11, 2000·Archives of Pathology & Laboratory Medicine·P L FitzgibbonsS J Schnitt
Nov 23, 2000·Nature·R A DePinho
Mar 20, 2001·Critical Reviews in Oncology/hematology·K M van TolT P Links
Mar 22, 2001·British Journal of Cancer·A ScorilasE P Diamandis
May 18, 2001·Nature·G I Evan, K H Vousden
Jan 30, 2002·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael Thun
Jun 22, 2002·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ida R K BukholmJahn M Nesland
Jul 18, 2002·Critical Reviews in Clinical Laboratory Sciences·Andreas Scorilas
Aug 30, 2002·The International Journal of Biochemistry & Cell Biology·Serenella Eppenberger-CastoriChristopher C Benz
Dec 11, 2003·The Journal of Urology·Carsten StephanEleftherios P Diamandis
May 21, 2004·Internal Medicine Journal·R D Snyder
Oct 21, 2004·Biological Chemistry·Konstantina MathioudakiMaroulio Talieri
Oct 30, 2004·Postgraduate Medicine·Larissa A KordeJoAnne Zujewski

❮ Previous
Next ❯

Citations

Jun 15, 2007·Cancer Chemotherapy and Pharmacology·Hellinida ThomadakiAndreas Scorilas
May 28, 2013·In Vitro Cellular & Developmental Biology. Animal·Mahdieh Sadat TaghaviGholamreza Javadi
Jan 13, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dimitrios Korbakis, Andreas Scorilas
Feb 7, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G F LehnerdtH S Bachmann
Oct 23, 2013·BMC Cancer·Sven-T LiffersAlireza Mirmohammadsadegh
Dec 29, 2013·Journal of Experimental & Clinical Cancer Research : CR·Dong YangPei-Hua Lu
Apr 24, 2008·Breast Cancer Research : BCR·Yasmine NadlerYuval Kluger
Nov 30, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wei LiLi Zhang
Sep 18, 2014·Clinical Biochemistry·Alexandros TzovarasAndreas Scorilas
Sep 24, 2011·Advances in Hematology·Flora TzifiAndreas Scorilas
Nov 6, 2009·Journal of Cancer Research and Clinical Oncology·Jin Hyang JungHo Yong Park
Jan 26, 2011·The Journal of Steroid Biochemistry and Molecular Biology·Guangfeng ZhaoYayi Hou
Jan 26, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·K M Arunasree
Jul 4, 2012·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Panagiota-Aikaterini GeomelaAndreas Scorilas
Sep 11, 2010·The Breast : Official Journal of the European Society of Mastology·Govindarajah VinothiniSiddavaram Nagini
Nov 12, 2009·Biochemical and Biophysical Research Communications·Dimitra FlorouAndreas Scorilas
Oct 22, 2008·Biochimica Et Biophysica Acta·Yi HongJianxing Gu
Sep 15, 2017·Nutrition and Cancer·Ratna Sudha Madempudi, Arunasree M Kalle
Sep 30, 2017·International Journal of Cancer. Journal International Du Cancer·Bindu ThapaHasan Uludağ
Oct 17, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·Athina Kladi-SkandaliAndreas Scorilas
Apr 30, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Amal Abd El-HafezBasem Hasan Elesawy
May 20, 2019·Cancer Biomarkers : Section a of Disease Markers·Aris I GiotakisEvangelos I Giotakis
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hagen S BachmannRainer Kimmig
Jan 11, 2007·Genes & Development·Alexander H SteghLynda Chin

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.